| Nippon India Pharma Fund Datagrid | ||||||
|---|---|---|---|---|---|---|
| Category | Pharma Fund | |||||
| BMSMONEY | Rank | - | ||||
| Rating | ||||||
| Growth Option 16-11-2026 | ||||||
| NAV | ₹585.1(R) | -0.02% | ₹659.36(D) | -0.02% | ||
| Returns | 1Y | 3Y | 5Y | 7Y | 10Y | |
| Lumpsum | Regular | 12.27% | 17.12% | 13.94% | 21.69% | 15.63% |
| Direct | 13.25% | 18.17% | 14.97% | 22.78% | 16.66% | |
| Benchmark | ||||||
| SIP (XIRR) | Regular | 20.37% | 12.38% | 16.88% | 17.52% | 17.85% |
| Direct | 21.39% | 13.37% | 17.94% | 18.59% | 18.9% | |
| Ratio | Sharpe Ratio | Sortino Ratio | Sterling Ratio | Jensen's Alpha | Treynor Ratio | |
| 0.94 | 0.48 | 0.86 | 0.44% | 0.17 | ||
| Risk | STD. Dev | VaR 1Y95% | Max DD | Beta | Semi Devi. | |
| 15.33% | -17.95% | -14.28% | 0.88 | 11.06% | ||
| Fund AUM | As on: 30/12/2025 | 8349 Cr | ||||
NAV Date: 16-11-2026
| Scheme Name | NAV | Rupee Change | Percent Change |
|---|---|---|---|
| NIPPON INDIA PHARMA FUND - IDCW Option | 126.35 |
-0.0300
|
-0.0200%
|
| NIPPON INDIA PHARMA FUND - DIRECT Plan - IDCW Option | 180.45 |
-0.0300
|
-0.0200%
|
| Nippon India Pharma Fund-Growth Plan-Growth Option | 585.1 |
-0.1400
|
-0.0200%
|
| Nippon India Pharma Fund-Growth Plan-Bonus Option | 585.1 |
-0.1400
|
-0.0200%
|
| Nippon India Pharma Fund - Direct Plan Growth Plan - Bonus Option | 659.36 |
-0.1200
|
-0.0200%
|
| Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option | 659.36 |
-0.1200
|
-0.0200%
|
Review Date: 16-11-2026
Standard deviation measures the fund's return volatility and Semi deviation focuses on downside volatility. Value at Risk (VaR) is a measure of the risk of investments. Maximum Drawdown is the maximum loss from a peak to a trough of a portfolio. Beta measures the volatility of the fund compared to the benchmark. A beta of 1 indicates that the fund will move in line with the benchmark. A beta of more than 1 indicates that the fund will be more volatile than the benchmark and vice versa.
Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.
Data Source: www.amfiindia.com
| KPIs* | Fund | Benchmark | Cat. Avg | Min | Max | Rank (In Cat.) | Performance |
|---|---|---|---|---|---|---|
| 1M Return % | 9.03 | 9.01 |
8.80
|
5.53 | 10.56 | 10 | 17 | Good |
| 3M Return % | 2.56 | 6.70 |
3.04
|
-0.27 | 6.75 | 10 | 17 | Good |
| 6M Return % | 7.10 | 13.89 |
12.76
|
5.60 | 18.92 | 15 | 17 | Average |
| 1Y Return % | 12.27 | 23.62 |
18.84
|
8.14 | 29.71 | 14 | 16 | Poor |
| 3Y Return % | 17.12 | 22.35 |
20.85
|
16.84 | 29.38 | 10 | 11 | Poor |
| 5Y Return % | 13.94 | 16.13 |
15.60
|
13.83 | 19.01 | 7 | 8 | Poor |
| 7Y Return % | 21.69 | 20.92 |
22.58
|
19.88 | 24.37 | 6 | 8 | Average |
| 10Y Return % | 15.63 | 11.05 |
14.96
|
14.30 | 15.63 | 1 | 4 | Very Good |
| 15Y Return % | 17.34 | 13.50 |
17.07
|
15.74 | 18.13 | 2 | 3 | Good |
| 1Y SIP Return % | 20.37 |
28.31
|
8.17 | 42.99 | 13 | 16 | Poor | |
| 3Y SIP Return % | 12.38 |
15.78
|
10.41 | 25.56 | 9 | 11 | Average | |
| 5Y SIP Return % | 16.88 |
18.98
|
15.82 | 22.45 | 7 | 8 | Poor | |
| 7Y SIP Return % | 17.52 |
18.98
|
16.60 | 21.70 | 6 | 8 | Average | |
| 10Y SIP Return % | 17.85 |
18.25
|
16.74 | 19.77 | 3 | 4 | Average | |
| 15Y SIP Return % | 16.62 |
16.50
|
15.87 | 17.01 | 2 | 3 | Good | |
| Standard Deviation | 15.33 |
15.95
|
14.65 | 16.87 | 2 | 8 | Very Good | |
| Semi Deviation | 11.06 |
11.39
|
10.68 | 12.13 | 4 | 8 | Good | |
| Max Drawdown % | -14.28 |
-14.76
|
-16.36 | -12.33 | 3 | 8 | Good | |
| VaR 1 Y % | -17.95 |
-18.95
|
-23.32 | -15.67 | 3 | 8 | Good | |
| Average Drawdown % | 5.68 |
5.47
|
3.66 | 6.79 | 4 | 8 | Good | |
| Sharpe Ratio | 0.94 |
1.04
|
0.87 | 1.20 | 7 | 8 | Poor | |
| Sterling Ratio | 0.86 |
0.94
|
0.81 | 1.09 | 7 | 8 | Poor | |
| Sortino Ratio | 0.48 |
0.54
|
0.44 | 0.63 | 7 | 8 | Poor | |
| Jensen Alpha % | 0.44 |
1.66
|
-0.46 | 3.84 | 5 | 8 | Average | |
| Treynor Ratio | 0.17 |
0.20
|
0.16 | 0.23 | 7 | 8 | Poor | |
| Modigliani Square Measure % | 15.52 |
17.20
|
14.35 | 19.86 | 7 | 8 | Poor | |
| Alpha % | -1.73 |
0.06
|
-1.73 | 3.02 | 8 | 8 | Poor |
| KPIs* | Fund | Benchmark | Cat. Avg | Min | Max | Rank (In Cat.) | Performance |
|---|---|---|---|---|---|---|
| 1M Return % | 9.11 | 9.01 | 8.92 | 5.67 | 10.65 | 10 | 17 | Good |
| 3M Return % | 2.78 | 6.70 | 3.38 | 0.07 | 7.15 | 11 | 17 | Average |
| 6M Return % | 7.55 | 13.89 | 13.50 | 6.24 | 19.83 | 15 | 17 | Average |
| 1Y Return % | 13.25 | 23.62 | 20.44 | 9.37 | 31.76 | 14 | 16 | Poor |
| 3Y Return % | 18.17 | 22.35 | 22.32 | 18.17 | 30.91 | 11 | 11 | Poor |
| 5Y Return % | 14.97 | 16.13 | 16.98 | 14.97 | 20.26 | 8 | 8 | Poor |
| 7Y Return % | 22.78 | 20.92 | 24.08 | 21.67 | 26.12 | 6 | 8 | Average |
| 10Y Return % | 16.66 | 11.05 | 16.27 | 16.08 | 16.66 | 1 | 4 | Very Good |
| 1Y SIP Return % | 21.39 | 30.01 | 9.57 | 45.19 | 13 | 16 | Poor | |
| 3Y SIP Return % | 13.37 | 17.18 | 12.03 | 27.01 | 9 | 11 | Average | |
| 5Y SIP Return % | 17.94 | 20.39 | 17.57 | 23.72 | 7 | 8 | Poor | |
| 7Y SIP Return % | 18.59 | 20.42 | 18.37 | 22.99 | 7 | 8 | Poor | |
| 10Y SIP Return % | 18.90 | 19.56 | 18.51 | 21.01 | 3 | 4 | Average | |
| Standard Deviation | 15.33 | 15.95 | 14.65 | 16.87 | 2 | 8 | Very Good | |
| Semi Deviation | 11.06 | 11.39 | 10.68 | 12.13 | 4 | 8 | Good | |
| Max Drawdown % | -14.28 | -14.76 | -16.36 | -12.33 | 3 | 8 | Good | |
| VaR 1 Y % | -17.95 | -18.95 | -23.32 | -15.67 | 3 | 8 | Good | |
| Average Drawdown % | 5.68 | 5.47 | 3.66 | 6.79 | 4 | 8 | Good | |
| Sharpe Ratio | 0.94 | 1.04 | 0.87 | 1.20 | 7 | 8 | Poor | |
| Sterling Ratio | 0.86 | 0.94 | 0.81 | 1.09 | 7 | 8 | Poor | |
| Sortino Ratio | 0.48 | 0.54 | 0.44 | 0.63 | 7 | 8 | Poor | |
| Jensen Alpha % | 0.44 | 1.66 | -0.46 | 3.84 | 5 | 8 | Average | |
| Treynor Ratio | 0.17 | 0.20 | 0.16 | 0.23 | 7 | 8 | Poor | |
| Modigliani Square Measure % | 15.52 | 17.20 | 14.35 | 19.86 | 7 | 8 | Poor | |
| Alpha % | -1.73 | 0.06 | -1.73 | 3.02 | 8 | 8 | Poor |
Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.
| Date | Nippon India Pharma Fund NAV Regular Growth | Nippon India Pharma Fund NAV Direct Growth |
|---|---|---|
| 16-11-2026 | 585.1034 | 659.3613 |
| 13-11-2026 | 585.2465 | 659.4767 |
| 12-11-2026 | 586.6782 | 661.0746 |
| 11-11-2026 | 588.5087 | 663.1218 |
| 09-11-2026 | 588.1467 | 662.683 |
| 06-11-2026 | 574.0981 | 646.809 |
| 05-11-2026 | 568.9138 | 640.9532 |
| 04-11-2026 | 566.9412 | 638.7159 |
| 03-11-2026 | 561.4642 | 632.5308 |
| 02-11-2026 | 557.6364 | 628.2039 |
| 30-10-2026 | 555.2364 | 625.4566 |
| 29-10-2026 | 552.3717 | 622.2151 |
| 28-10-2026 | 550.4816 | 620.0717 |
| 27-10-2026 | 542.844 | 611.4543 |
| 26-10-2026 | 533.473 | 600.885 |
| 23-10-2026 | 524.8618 | 591.1445 |
| 22-10-2026 | 527.8479 | 594.4939 |
| 21-10-2026 | 528.6359 | 595.3675 |
| 19-10-2026 | 531.1304 | 598.1491 |
| 16-10-2026 | 536.6384 | 604.31 |
| Fund Launch Date: 10/May/2004 |
| Fund Category: Pharma Fund |
| Investment Objective: The Fund seeks to invest in pharma sector with focus on important segments of the sector viz Domestic Business, International & CRAMS and include deep value as well as high growth pharma businesses. The fund invests across market capitalization within the sector. It may suit investment horizon of around 2-3 years |
| Fund Description: An open ended equity scheme investing in pharma sector |
| Fund Benchmark: S&P BSE Healthcare TR |
Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.